- Home
- KURA vs AVNS Comparison
KURA vs AVNS Comparison
Compare KURA & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- AVNS
- Stock Information
- Founded
- KURA 2014
- AVNS 2014
- Country
- KURA United States
- AVNS United States
- Employees
- KURA N/A
- AVNS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- AVNS Industrial Specialties
- Sector
- KURA Health Care
- AVNS Health Care
- Exchange
- KURA Nasdaq
- AVNS Nasdaq
- Market Cap
- KURA 561.9M
- AVNS 591.9M
- IPO Year
- KURA N/A
- AVNS N/A
- Fundamental
- Price
- KURA $6.47
- AVNS $11.88
- Analyst Decision
- KURA Strong Buy
- AVNS
- Analyst Count
- KURA 12
- AVNS 0
- Target Price
- KURA $24.50
- AVNS N/A
- AVG Volume (30 Days)
- KURA 1.4M
- AVNS 419.0K
- Earning Date
- KURA 08-07-2025
- AVNS 08-05-2025
- Dividend Yield
- KURA N/A
- AVNS N/A
- EPS Growth
- KURA N/A
- AVNS N/A
- EPS
- KURA N/A
- AVNS N/A
- Revenue
- KURA $67,991,000.00
- AVNS $689,200,000.00
- Revenue This Year
- KURA $125.04
- AVNS N/A
- Revenue Next Year
- KURA $83.75
- AVNS $3.42
- P/E Ratio
- KURA N/A
- AVNS N/A
- Revenue Growth
- KURA N/A
- AVNS 1.34
- 52 Week Low
- KURA $5.41
- AVNS $11.21
- 52 Week High
- KURA $21.60
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- KURA 55.28
- AVNS 47.94
- Support Level
- KURA $6.26
- AVNS $11.21
- Resistance Level
- KURA $6.74
- AVNS $12.14
- Average True Range (ATR)
- KURA 0.31
- AVNS 0.39
- MACD
- KURA 0.05
- AVNS 0.02
- Stochastic Oscillator
- KURA 75.25
- AVNS 51.94
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.